| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 3/6 |
| Financial Health | 4/6 |
| Dividends | 2/6 |
Zhejiang East Asia Pharmaceutical Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥25.31 |
| 52 Week High | CN¥34.89 |
| 52 Week Low | CN¥14.96 |
| Beta | 0.41 |
| 1 Month Change | 24.43% |
| 3 Month Change | 10.09% |
| 1 Year Change | 3.52% |
| 3 Year Change | -31.19% |
| 5 Year Change | n/a |
| Change since IPO | -43.54% |
Recent News & Updates
Zhejiang East Asia Pharmaceutical Co., Ltd. (SHSE:605177) Stock Catapults 26% Though Its Price And Business Still Lag The Market
Apr 23
Take Care Before Diving Into The Deep End On Zhejiang East Asia Pharmaceutical Co., Ltd. (SHSE:605177)
Feb 28Shareholder Returns
| 605177 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | -2.6% | 0.8% | -0.4% |
| 1Y | 3.5% | -13.4% | -14.4% |
Return vs Industry: 605177 exceeded the CN Pharmaceuticals industry which returned -13.4% over the past year.
Return vs Market: 605177 exceeded the CN Market which returned -14.4% over the past year.
Price Volatility
| 605177 volatility | |
|---|---|
| 605177 Average Weekly Movement | 7.9% |
| Pharmaceuticals Industry Average Movement | 7.7% |
| Market Average Movement | 8.8% |
| 10% most volatile stocks in CN Market | 12.7% |
| 10% least volatile stocks in CN Market | 5.2% |
Stable Share Price: 605177's share price has been volatile over the past 3 months.
Volatility Over Time: 605177's weekly volatility (8%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1992 | 1,435 | Cheng Chi | www.eapharm.cn |
Zhejiang East Asia Pharmaceutical Co., Ltd. produces and sells pharmaceutical chemicals, tablets, granules, intermediates, and capsules. It offers quinolones synthetic antibacterial agents, antifungal products, gastrointestinal medications, semi-synthetic cephalosporin antibiotics, carbapenem antibiotics, antiviral agents, central nervous system medications, respiratory drugs, antiallergic agents, antineoplastic agents and tumor adjuvant drugs, and other products.
Zhejiang East Asia Pharmaceutical Co., Ltd. Fundamentals Summary
| 605177 fundamental statistics | |
|---|---|
| Market cap | CN¥2.88b |
| Earnings (TTM) | CN¥121.25m |
| Revenue (TTM) | CN¥1.36b |
23.7x
P/E Ratio2.1x
P/S RatioIs 605177 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 605177 income statement (TTM) | |
|---|---|
| Revenue | CN¥1.36b |
| Cost of Revenue | CN¥995.09m |
| Gross Profit | CN¥361.36m |
| Other Expenses | CN¥240.11m |
| Earnings | CN¥121.25m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Apr 30, 2024
| Earnings per share (EPS) | 1.07 |
| Gross Margin | 26.64% |
| Net Profit Margin | 8.94% |
| Debt/Equity Ratio | 34.8% |
How did 605177 perform over the long term?
See historical performance and comparison